IRIX Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2024Q3

FY2024Q4

FY2025Q1

12.50M

-2.72%

12.80M

+2.75%

12.10M

+2.88%

Estimates Revision

The market is revising No Change the revenue expectations for IRIDEX Corporation (IRIX) for FY2024, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 6.25%.

Revenue Estimates for FY2024

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2024

No Change

0.00%

In Past 3 Month

Stock Price

Go Up

+6.25%

In Past 3 Month

Valuation Metrics

The current forward P/E ratio for IRIDEX Corp (IRIX.O) is -4.33, compared to its 5-year average forward P/E of -8.00. For a more detailed relative valuation and DCF analysis to assess IRIDEX Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-8.00

Current PE

-4.33

Overvalued PE

-2.93

Undervalued PE

-13.07

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-7.92

Current EV/EBITDA

-10.13

Overvalued EV/EBITDA

-3.29

Undervalued EV/EBITDA

-12.56

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

0.92

Current PS

0.39

Overvalued PS

1.50

Undervalued PS

0.34

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

IRIX News & Events

Events Timeline

No data

News

3.5

2025-12-11Newsfilter

Iridex's MicroPulse Technology Effectively Lowers Intraocular Pressure in Glaucoma Patients

3.5

2025-12-08Globenewswire

Iridex Publishes Study on Thermal Dynamics of Laser Treatments for Glaucoma

3.5

2025-12-08Newsfilter

Iridex Publishes Study on Thermal Dynamics of Laser Treatments for Glaucoma

People Also Watch

Frequently Asked Questions

What is IRIDEX Corp (IRIX) stock price today?

The current price of IRIX is 1.19 USD — it has increased 0 % in the last trading day.

What is IRIDEX Corp (IRIX)'s business?

IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.

What is the price predicton of IRIX Stock?

Wall Street analysts forecast IRIX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for IRIX is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is IRIDEX Corp (IRIX)'s revenue for the last quarter?

IRIDEX Corp revenue for the last quarter amounts to 12.48M USD, increased 7.80 % YoY.

What is IRIDEX Corp (IRIX)'s earnings per share (EPS) for the last quarter?

IRIDEX Corp. EPS for the last quarter amounts to -0.09 USD, decreased -25.00 % YoY.

What changes have occurred in the market's expectations for IRIDEX Corp (IRIX)'s fundamentals?

How many employees does IRIDEX Corp (IRIX). have?

IRIDEX Corp (IRIX) has 93 emplpoyees as of January 09 2026.

What is IRIDEX Corp (IRIX) market cap?

Today IRIX has the market capitalization of 20.46M USD.